1. Home
  2. BKH vs STVN Comparison

BKH vs STVN Comparison

Compare BKH & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Black Hills Corporation

BKH

Black Hills Corporation

HOLD

Current Price

$72.19

Market Cap

5.5B

Sector

Utilities

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$14.99

Market Cap

4.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKH
STVN
Founded
1941
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Electric Utilities: Central
Containers/Packaging
Sector
Utilities
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.2B
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
BKH
STVN
Price
$72.19
$14.99
Analyst Decision
Buy
Buy
Analyst Count
3
3
Target Price
$76.33
$25.67
AVG Volume (30 Days)
830.8K
565.5K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
3.98%
0.43%
EPS Growth
1.79
N/A
EPS
3.98
N/A
Revenue
$2,310,000,000.00
N/A
Revenue This Year
$5.32
$10.26
Revenue Next Year
$3.82
$10.02
P/E Ratio
$17.72
$27.15
Revenue Growth
8.57
N/A
52 Week Low
$54.92
$13.91
52 Week High
$75.83
$28.00

Technical Indicators

Market Signals
Indicator
BKH
STVN
Relative Strength Index (RSI) 47.45 43.56
Support Level $70.78 $14.03
Resistance Level $73.75 $17.14
Average True Range (ATR) 1.68 0.87
MACD -0.38 0.04
Stochastic Oscillator 46.63 25.11

Price Performance

Historical Comparison
BKH
STVN

About BKH Black Hills Corporation

Black Hills Corp is a U.S.-based energy company that operates through its Electric Utilities and Gas Utilities segment. These segments operate in states in the Midwest and mountain regions in the U.S. The company's customers include residential, commercial, industrial, and municipal consumers. These customers are residential. Black Hills derives the majority of its revenue from its utility business group, specifically from gas utilities.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: